4-aminobenzoic acid and palbociclib

4-aminobenzoic acid has been researched along with palbociclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Algeo, MP; Chaire, V; Derieppe, MA; Italiano, A; Laroche-Clary, A; Loarer, FL	1

Other Studies

1 other study(ies) available for 4-aminobenzoic acid and palbociclib

Article	Year
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas. Journal of hematology & oncology, 2017, 06-19, Volume: 10, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Drug Synergism; Female; Humans; Liposarcoma; Mice; Molecular Targeted Therapy; para-Aminobenzoates; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyridines; Pyrrolidines	2017

Article

Year

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas.

Journal of hematology & oncology, 2017, 06-19, Volume: 10, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Drug Synergism; Female; Humans; Liposarcoma; Mice; Molecular Targeted Therapy; para-Aminobenzoates; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyridines; Pyrrolidines

2017